Q1 2023 13F Holders as of 3/31/2023
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
374M
-
Number of holders
-
68
-
Total 13F shares, excl. options
-
46.1M
-
Shares change
-
-389K
-
Total reported value, excl. options
-
$89.9M
-
Value change
-
-$84.8K
-
Put/Call ratio
-
29.46
-
Number of buys
-
29
-
Number of sells
-
-23
-
Price
-
$1.95
Significant Holders of STANDARD BIOTOOLS INC. - Common Stock, par value $0.001 per share (LAB) as of Q1 2023
81 filings reported holding LAB - STANDARD BIOTOOLS INC. - Common Stock, par value $0.001 per share as of Q1 2023.
STANDARD BIOTOOLS INC. - Common Stock, par value $0.001 per share (LAB) has 68 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 46.1M shares
of 374M outstanding shares and own 12.31% of the company stock.
Largest 10 shareholders include Caligan Partners LP (8.58M shares), Indaba Capital Management, L.P. (7.45M shares), NEUBERGER BERMAN GROUP LLC (4.51M shares), PRIMECAP MANAGEMENT CO/CA/ (4.5M shares), VANGUARD GROUP INC (3.96M shares), MORGAN STANLEY (3.2M shares), NEEDHAM INVESTMENT MANAGEMENT LLC (2.87M shares), BOOTHBAY FUND MANAGEMENT, LLC (2.3M shares), BlackRock Inc. (1.42M shares), and HighTower Advisors, LLC (993K shares).
This table shows the top 68 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.